Source: European Medicines Agency (EU) Revision Year: 2019 Publisher: Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands
YENTREVE 20 mg hard gastro-resistant capsules.
| Pharmaceutical Form |
|---|
|
Hard gastro-resistant capsule. Opaque blue body, imprinted with ‘20 mg’ and an opaque blue cap, imprinted with ‘9544’. |
Each capsule contains 20 mg of duloxetine (as hydrochloride).
Excipient(s) with known effect: Each capsule may contain up to 37 mg sucrose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Duloxetine |
Duloxetine is a combined serotonin (5-HT) and noradrenaline (NA) reuptake inhibitor. It weakly inhibits dopamine reuptake with no significant affinity for histaminergic, dopaminergic, cholinergic and adrenergic receptors. |
| List of Excipients |
|---|
|
Capsule content: Hypromellose Capsule shell: Gelatin Edible ink: Black iron oxide – synthetic (E172) |
Polyvinylchloride (PVC), polyethylene (PE), and polychlorotrifluoroethylene (PCTFE) blister sealed with an aluminium foil.
Packs of 28, 56 and 98 capsules.
Not all pack sizes may be marketed.
Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands
EU/1/04/280/001
EU/1/04/280/007
EU/1/04/280/008
Date of first authorisation: 11 August 2004
Date of latest renewal: 24 June 2009
| Drug | Countries | |
|---|---|---|
| YENTREVE | Austria, Germany, Estonia, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Poland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
